Literature DB >> 14527549

Solution-phase synthesis of novel delta2-isoxazoline libraries via 1,3-dipolar cycloaddition and their antifungal properties.

M P Sadashiva, K Mantelingu, S Nanjunda Swamy, K S Rangappa.   

Abstract

The synthesis of novel imidazolyl substituted delta2-isoxazoline libraries are currently of high interest. We report here in the full details of a study leading to the synthesis and antifungal activities of 3-(-2-butyl-4-chloro-1H-imidazolyl)-substituted delta2-isoxazolines. The solution phase synthesis of the title compounds was accomplished via 1,3-dipolar cycloaddition of in situ generated nitryl oxides from aldoximes with mono substituted alkenes to obtain the compound libraries contain an imidazole functionality in addition to the isoxazoline rings. The newly synthesized compounds when tested in vitro in solid agar culture exerted a potent antifungal activity against Aspergillus flavus, Fusarium moniliforme and Botrydiplodia theobromae also MIC values were determined. The title 5-substituted-3-imidazolyl-delta2-isoxazoline compounds represent a novel class of potent antifungal agents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14527549     DOI: 10.1016/j.bmc.2003.08.007

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  8 in total

Review 1.  Nitrogen-Containing Heterocyclic Compounds Obtained from Monoterpenes or Their Derivatives: Synthesis and Properties.

Authors:  Vladimir V Chernyshov; Irina I Popadyuk; Olga I Yarovaya; Nariman F Salakhutdinov
Journal:  Top Curr Chem (Cham)       Date:  2022-08-11

2.  Anti-cancer activity of novel dibenzo[b,f]azepine tethered isoxazoline derivatives.

Authors:  Maralinganadoddi Panchegowda Sadashiva; Shivananju NanjundaSwamy; Feng Li; Kanjoormana Aryan Manu; Murugan Sengottuvelan; Doddakunche Shivaramu Prasanna; Nirvanappa Chikkagundagal Anilkumar; Gautam Sethi; Kazuyuki Sugahara; Kanchugarakoppal Subbegowda Rangappa
Journal:  BMC Chem Biol       Date:  2012-10-03

3.  5-Methyl-3-phenyl-isoxazole-4-carb-oxy-lic acid.

Authors:  N Srikantamurthy; G J Vishalakshi; S Jeyaseelan; K B Umesha; M Mahendra
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-05-15

4.  Synthesis and characterization of novel 2-amino-chromene-nitriles that target Bcl-2 in acute myeloid leukemia cell lines.

Authors:  Hosadurga K Keerthy; Manoj Garg; Chakrabhavi D Mohan; Vikas Madan; Deepika Kanojia; Rangappa Shobith; Shivananju Nanjundaswamy; Daniel J Mason; Andreas Bender; Kanchugarakoppal S Rangappa; H Phillip Koeffler
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

5.  Novel apigenin based small molecule that targets snake venom metalloproteases.

Authors:  Venkatachalaiah Srinivasa; Mahalingam S Sundaram; Sebastian Anusha; Mahadevappa Hemshekhar; Siddaiah Chandra Nayaka; Kempaiah Kemparaju; Kesturu S Girish; Kanchugarakoppal S Rangappa
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

6.  A Nano-MgO and Ionic Liquid-Catalyzed 'Green' Synthesis Protocol for the Development of Adamantyl-Imidazolo-Thiadiazoles as Anti-Tuberculosis Agents Targeting Sterol 14α-Demethylase (CYP51).

Authors:  Sebastian Anusha; Baburajeev Cp; Chakrabhavi Dhananjaya Mohan; Jessin Mathai; Shobith Rangappa; Surender Mohan; Shardul Paricharak; Lewis Mervin; Julian E Fuchs; Mahedra M; Andreas Bender; Kanchugarakoppal S Rangappa
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

7.  Evaluation of anti-inflammatory activity and molecular docking study of new aza-bicyclic isoxazoline acylhydrazone derivatives.

Authors:  Fernanda Virginia Barreto Mota; Marlene Saraiva de Araújo Neta; Eryvelton de Souza Franco; Isla Vanessa Gomes Alves Bastos; Larissa Cardoso Correia da Araújo; Sandra Cabral da Silva; Tatiane Bezerra de Oliveira; Eduarda Karynne Souza; Valderes Moraes de Almeida; Rafael Matos Ximenes; Maria Bernadete de Sousa Maia; Francisco Jaime Bezerra Mendonça Junior; Pascal Marchand; Antônio Rodolfo de Faria; Teresinha Gonçalves da Silva
Journal:  Medchemcomm       Date:  2019-09-12       Impact factor: 3.597

8.  (E)-Benzaldehyde O-{[3-(pyridin-3-yl)isoxazol-5-yl]meth-yl}oxime.

Authors:  Rodolfo Moreno-Fuquen; Alix Elena Loaiza; John Diaz-Velandia; Alan R Kennedy; Catriona A Morrison
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-03-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.